https://www.linkedin.com/jobs/view/3685246470/
Head of Global Commercialization - TLX250 CDx
Telix Pharmaceuticals Limited · Fishers, IN · 1 day ago
About the job
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.
See Yourself at Telix
The Head of Global Commercialization - TLX250 CDx (Zirconium (89Zr) girentuximab senvedoxam) is responsible for the business management of the asset and its commercial success. The prime responsibility is leading a multidisciplinary global matrix team to ensure regulatory goals are met. The position is responsible for all activities related to both product planning and product marketing including managing the asset throughout the product development, product lifecycle, prioritizing product/customer requirements, defining the product vision, and working closely with all stakeholders to deliver a winning strategy.
Key Accountabilities
- Manage the product lifecycle from end of Phase II to maximize commercial outcomes
- Manage product profitability and commercial success
- Collect and manage market research, market access and competitive intelligence relevant to the asset
- Evaluate product functionality and drives present/future product direction
- Own the product roadmap, including the plan, organization, and execution for all activities for the asset
- Drive coordination and delivery through all functional relationships - clinical operations, regulatory affairs, manufacturing, quality
- Complete and smooth transition from Phase II team to Phase III team
- Coordinate and drive all activities related to Phase III trials
- Collaborate and drive the project with Manufacturing, Medical Affairs, Regulatory Affairs, Supply Chain, and other keystakeholders to ensure seamless communication and integration of commercial strategies throughout the product life cycle
- Establish and track key performance indicators (KPIs) to evaluate the success of commercialization efforts, providing regular performance reports to senior management
- Monitor and act on risks and opportunities, including escalating as appropriate
- Develop, maintain and present reporting as required
Key Capabilities
- Commitment to excellence: Take pride in your work and consistently strive for excellence in everything you do
- Results-oriented: Driven to achieve goals and objectives, with a strong focus on delivering measurable results
- Ethical behavior: Act with integrity and demonstrate a commitment to ethical behavior in all interactions with colleagues and stakeholders
- Adaptability: Comfortable working in a dynamic environment, able to adjust to changing priorities, and willing to take on new challenges
- Strong communication skills: Able to communicate effectively with colleagues and stakeholders at all levels, using clear and concise language
- Collaboration: Work effectively as leader of a team, actively sharing knowledge and expertise to achieve common goals
- Resilience: Demonstrate the ability to bounce back from setbacks and persevere in the face of challenges
- Continuous learning: Show a commitment to ongoing learning and professional development, continually seeking out opportunities to expand your knowledge and skills
- Inclusive mindset: Demonstrate an understanding and appreciation for diversity, and actively work to create an inclusive environment where everyone feels valued and respected
- Creativity and innovation: Possess a willingness to think outside the box and come up with unique and creative solutions to challenges
Education And Experience
- Postgraduate qualifications in marketing, business or life sciences required
- Minimum 10 years' experience of project management leading a cross-functional matrix team without formal authority
- Exceptional leadership and strategic planning skills, with the ability to drive cross-functional teams towards common goals
- Prior commercial experiences in the pharmaceutical/biotechnology industry in sales/marketing and product management with a focus in imaging, radiopharmaceuticals or oncology is preferred
- Proven track record in launch strategy development and managing pre-launch activities to drive revenue and profits
- Excellent analytical and problem-solving abilities, with a data-driven approach to decision-making
- Outstanding communication and interpersonal skills to effectively collaborate and lead stakeholders at all levels
- Demonstrated ability to adapt to a fast-paced and evolving global market environment
- Knowledge of regulatory requirements and compliance in the pharmaceutical industry
- Ability to conduct competitive environment analysis and understand market segments and customer needs to effectively translate into clear marketing requirements
- Ability to advise on business case justifications for new products and improvements of the product portfolio.
- Experience in delivering finely tuned product upstream marketing strategies
- Exceptional writing and editing skills, combined with strong presentation and public speaking skills
- Strong learning agility and a desire to gain new skills and experience
- Forums
- ASX - By Stock
- TLX
- Ann: ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU
Ann: ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU, page-42
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.43 |
Change
0.470(2.62%) |
Mkt cap ! $6.167B |
Open | High | Low | Value | Volume |
$18.15 | $18.74 | $18.09 | $22.34M | 1.208M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1076 | $18.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.44 | 1219 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1076 | 18.430 |
2 | 7781 | 18.410 |
1 | 2476 | 18.400 |
1 | 4288 | 18.380 |
1 | 4288 | 18.340 |
Price($) | Vol. | No. |
---|---|---|
18.440 | 1219 | 1 |
18.450 | 1069 | 1 |
18.470 | 2147 | 1 |
18.480 | 350 | 1 |
18.500 | 49 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |